Vieworks Co., Ltd.
₩26,750-₩950 (-3.43%)
Vieworks Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 23.35% below the high.
KOE · 036220.KQ · KRW
Stock price, dividends
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
Osang Healthcare Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 65.14% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
THE COMPANY BEHIND THE TICKER
Osang Healthcare Co.,Ltd, based in Anyang, South Korea, is a company focused on the innovation, advancement, and global commercialization of diverse diagnostic biosensing solutions. Their comprehensive product offerings include tests for key health markers such as blood glucose, hemoglobin A1c, and cholesterol, in addition to sophisticated immuno- and molecular diagnostic technologies. These cutting-edge products reach approximately 110 nations across the globe. Established in 1996, the firm operated as Infopia Co., Ltd. until its rebranding to Osang Healthcare Co.,Ltd in April 2017.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:40 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩26,750-₩950 (-3.43%)
Vieworks Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 23.35% below the high.
₩5,260-₩90 (-1.68%)
EASY BIO,Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.55% below the high.
₩7,650-₩40 (-0.52%)
Samil Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 40.51% below the high.
₩10,510-₩80 (-0.76%)
JW Lifescience Corporation’s quoted price sits in the lower half of its reported 52-week range, 32.54% below the high.
₩13,950-₩290 (-2.04%)
Interojo Inc.’s quoted price sits in the lower half of its reported 52-week range, 39.61% below the high.
₩8,070-₩160 (-1.94%)
Hana Pharm Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.3% below the high.
₩5,020-₩40 (-0.79%)
DongBang Medical’s quoted price sits in the lower half of its reported 52-week range, 48.03% below the high.
₩1,924+₩4 (+0.21%)
Access Bio, Inc.’s quoted price sits in the lower half of its reported 52-week range, 59.11% below the high.